CN101687921A - 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白 - Google Patents

可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白 Download PDF

Info

Publication number
CN101687921A
CN101687921A CN200780053734A CN200780053734A CN101687921A CN 101687921 A CN101687921 A CN 101687921A CN 200780053734 A CN200780053734 A CN 200780053734A CN 200780053734 A CN200780053734 A CN 200780053734A CN 101687921 A CN101687921 A CN 101687921A
Authority
CN
China
Prior art keywords
binding protein
antibody
monoclonal antibody
subtype
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200780053734A
Other languages
English (en)
Chinese (zh)
Inventor
Y·F·胡
Q·Y·杜
F·和
J·H-S·康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temasek Life Sciences Laboratory Ltd
Original Assignee
Temasek Life Sciences Laboratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temasek Life Sciences Laboratory Ltd filed Critical Temasek Life Sciences Laboratory Ltd
Publication of CN101687921A publication Critical patent/CN101687921A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN200780053734A 2007-05-11 2007-05-11 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白 Pending CN101687921A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2007/000134 WO2008140415A1 (en) 2007-05-11 2007-05-11 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201210181724.1A Division CN102718863B (zh) 2007-05-11 2007-05-11 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白

Publications (1)

Publication Number Publication Date
CN101687921A true CN101687921A (zh) 2010-03-31

Family

ID=40002472

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780053734A Pending CN101687921A (zh) 2007-05-11 2007-05-11 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白

Country Status (8)

Country Link
US (3) US8540994B2 (enExample)
EP (2) EP2155787A4 (enExample)
JP (1) JP5597128B2 (enExample)
KR (1) KR101421460B1 (enExample)
CN (1) CN101687921A (enExample)
AU (1) AU2007353481B2 (enExample)
CA (1) CA2687147C (enExample)
WO (1) WO2008140415A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101993492A (zh) * 2010-11-25 2011-03-30 南京医科大学 抗H5N1型高致病性禽流感scFv抗体及其应用
CN112334481A (zh) * 2018-06-11 2021-02-05 葛兰素史克消费保健（美国）控股有限责任公司 用于快速乙型流感诊断测试的抗体对

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101421460B1 (ko) * 2007-05-11 2014-07-30 테마섹 라이프 사이언스 래보러토리 리미티드 Ｈ５ 조류 인플루엔자 진단 및 감시를 위해 유용한 ｈ５ 서브타입-특이적 결합 단백질
SG183031A1 (en) * 2007-09-13 2012-08-30 Temasek Life Sciences Lab Ltd Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
US8444986B2 (en) 2007-09-13 2013-05-21 Temasek Life Sciences Laboratory Limited Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof
JP5490725B2 (ja) * 2008-02-05 2014-05-14 テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド Ｈ５亜型インフルエンザウイルスの普遍的な検出のための結合タンパク質およびエピトープブロッキングｅｌｉｓａ
CN102292350A (zh) 2008-12-24 2011-12-21 淡马锡生命科学研究院有限公司 对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途
WO2012054745A1 (en) * 2010-10-20 2012-04-26 New York Blood Center, Inc. Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
JP2013087069A (ja) * 2011-10-17 2013-05-13 Toyobo Co Ltd Ｈ５亜型インフルエンザウイルスを特異的に認識するモノクローナル抗体
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
TWI702229B (zh) 2014-12-19 2020-08-21 美商再生元醫藥公司 流行性感冒病毒血球凝集素之人類抗體
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN109195629A (zh) 2016-02-24 2019-01-11 威特拉公司 流行性感冒抗体分子制剂
US11780907B2 (en) 2018-01-26 2023-10-10 Regeneron Pharmaceuticals, Inc. Human antibodies to influenza hemagglutinin
CA3132521A1 (en) 2019-03-25 2020-10-01 Visterra, Inc. Compositions and methods for treating and preventing influenza
KR102517114B1 (ko) * 2020-08-28 2023-04-03 원광대학교산학협력단 고병원성 조류 인플루엔자 바이러스 h5 아형에 특이적인 단클론항체 및 이를 이용한 신속 진단 키트
KR102605065B1 (ko) * 2021-10-14 2023-11-22 원광대학교산학협력단 고병원성 조류 인플루엔자 바이러스 h5n1에 특이적인 단클론항체 및 이를 이용한 신속 진단 키트

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
WO2003102246A1 (en) * 2002-05-31 2003-12-11 Penn State Research Foundation Dot-elisa for the detection of animal viruses
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
US7037707B2 (en) * 2003-09-04 2006-05-02 St. Jude Children's Research Hospital Method for generating influenza viruses and vaccines
EP1819357A4 (en) * 2004-12-09 2009-02-25 Univ Pittsburgh VACCINES FOR FAST RESPONSE TO A BIRD GRIP PANDEMY
CA2616561C (en) * 2005-07-25 2018-12-18 Avianax, Llc Therapeutic goose antibodies for treatment and prophylaxis of transmittable viral diseases
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
US20070087336A1 (en) * 2005-10-17 2007-04-19 Rangarajan Sampath Compositions for use in identification of influenza viruses
US20070092524A1 (en) * 2005-10-21 2007-04-26 Jacob Nusbacher Method for the treatment and prophylaxis of avian influenza infection
JP2009524434A (ja) * 2006-01-26 2009-07-02 エイチエックス・ダイアグノスティックス・インコーポレイテッド トリインフルエンザウイルス亜型ｈ５ヘマグルチニンに結合するモノクローナル抗体およびそれらの使用
CN101460628B (zh) * 2006-05-05 2013-03-27 淡马锡生命科学研究院有限公司 生物分子表面展示及其用途
EP2035454A2 (en) * 2006-05-19 2009-03-18 Amgen, Inc. Antibodies to sars coronavirus
KR101421460B1 (ko) * 2007-05-11 2014-07-30 테마섹 라이프 사이언스 래보러토리 리미티드 Ｈ５ 조류 인플루엔자 진단 및 감시를 위해 유용한 ｈ５ 서브타입-특이적 결합 단백질
US8444986B2 (en) * 2007-09-13 2013-05-21 Temasek Life Sciences Laboratory Limited Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof
SG183031A1 (en) * 2007-09-13 2012-08-30 Temasek Life Sciences Lab Ltd Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
JP5490725B2 (ja) * 2008-02-05 2014-05-14 テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド Ｈ５亜型インフルエンザウイルスの普遍的な検出のための結合タンパク質およびエピトープブロッキングｅｌｉｓａ
CN102292350A (zh) * 2008-12-24 2011-12-21 淡马锡生命科学研究院有限公司 对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101993492A (zh) * 2010-11-25 2011-03-30 南京医科大学 抗H5N1型高致病性禽流感scFv抗体及其应用
CN112334481A (zh) * 2018-06-11 2021-02-05 葛兰素史克消费保健（美国）控股有限责任公司 用于快速乙型流感诊断测试的抗体对

Also Published As

Publication number Publication date
JP5597128B2 (ja) 2014-10-01
US8637644B2 (en) 2014-01-28
HK1161725A1 (en) 2012-08-03
CA2687147C (en) 2016-08-23
AU2007353481A1 (en) 2008-11-20
EP2155787A4 (en) 2010-06-16
EP2363415A3 (en) 2011-12-14
KR20100049506A (ko) 2010-05-12
US8540994B2 (en) 2013-09-24
CA2687147A1 (en) 2008-11-20
EP2363415B1 (en) 2013-07-31
WO2008140415A1 (en) 2008-11-20
US8637645B2 (en) 2014-01-28
JP2010526880A (ja) 2010-08-05
US20110003278A1 (en) 2011-01-06
EP2155787A1 (en) 2010-02-24
US20130004944A1 (en) 2013-01-03
US20130004943A1 (en) 2013-01-03
WO2008140415A9 (en) 2009-01-15
EP2363415A2 (en) 2011-09-07
KR101421460B1 (ko) 2014-07-30
AU2007353481B2 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
EP2363415B1 (en) H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
US8540996B2 (en) Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
US9115188B2 (en) Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof
CN102718863A (zh) 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白
HK1161725B (en) H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
WO2010110737A1 (en) Monoclonal antibody against a conserved domain of m2e polypeptide in influenza viruses
AU2013224734A1 (en) Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100331